Elixinol Wellness Limited
ELLXF
$0.012
$0.000.00%
OTC PK
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -2.75% | 22.88% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -2.75% | 22.88% | |||
| Cost of Revenue | -2.74% | 22.38% | |||
| Gross Profit | -2.75% | 23.77% | |||
| SG&A Expenses | -2.75% | 3.14% | |||
| Depreciation & Amortization | -2.78% | -4.35% | |||
| Other Operating Expenses | -2.72% | 203.57% | |||
| Total Operating Expenses | -2.75% | 14.52% | |||
| Operating Income | 2.75% | 6.96% | |||
| Income Before Tax | 2.74% | 5.66% | |||
| Income Tax Expenses | 2.74% | -401,000.00% | |||
| Earnings from Continuing Operations | -2.74% | 138.15% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -2.74% | 138.15% | |||
| EBIT | 2.75% | 6.96% | |||
| EBITDA | 2.73% | 8.28% | |||
| EPS Basic | -5.26% | 126.03% | |||
| Normalized Basic EPS | 3.45% | 34.09% | |||
| EPS Diluted | -5.26% | 125.68% | |||
| Normalized Diluted EPS | 3.45% | 34.09% | |||
| Average Basic Shares Outstanding | 0.00% | 47.80% | |||
| Average Diluted Shares Outstanding | 0.00% | 47.80% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||